{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:58:59Z","timestamp":1764935939332},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","funder":[{"name":"Sichuan Provincial Science and Technology Support Project","award":["2019YJ0129"],"award-info":[{"award-number":["2019YJ0129"]}]},{"name":"National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University","award":["Z2018B22"],"award-info":[{"award-number":["Z2018B22"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1097\/md.0000000000022267","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T18:06:43Z","timestamp":1600452403000},"page":"e22267","source":"Crossref","is-referenced-by-count":5,"title":["Comparative efficacy of intravitreal pharmacotherapy for macular edema secondary to retinal vein occlusion"],"prefix":"10.1097","volume":"99","author":[{"given":"Yun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiancong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"R1-20230103","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40942-015-0005-8","article-title":"A review of optical coherence tomography angiography (OCTA)","volume":"1","author":"de Carlo","year":"2015","journal-title":"Int J Retina Vitreous"},{"key":"R2-20230103","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/jth.12982","article-title":"Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study","volume":"13","author":"Ponto","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R3-20230103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"R4-20230103","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09286586.2015.1082604","article-title":"Retinal vein occlusion in a multi-ethnic Asian population: The Singapore Epidemiology of Eye Disease Study","volume":"23","author":"Koh","year":"2016","journal-title":"Ophthalmic Epidemiol"},{"key":"R5-20230103","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2147\/OPTH.S7631","article-title":"Retinal vein occlusion: pathophysiology and treatment options","volume":"4","author":"Karia","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"R6-20230103","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1167\/iovs.08-2510","article-title":"Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab","volume":"50","author":"Funk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20230103","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: beyond the surface","volume":"63","author":"Daruich","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R8-20230103","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10384-018-0586-5","article-title":"Mechanisms of vision loss in eyes with macular edema associated with retinal vein occlusion","volume":"62","author":"Iijima","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"R9-20230103","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bjo.61.12.741","article-title":"Panretinal photocoagulation in central retinal vein occlusion: a randomised controlled clinical study","volume":"61","author":"Laatikainen","year":"1977","journal-title":"Br J Ophthalmol"},{"key":"R10-20230103","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group","volume":"98","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"R11-20230103","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"R12-20230103","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0161-6420(95)30848-2","article-title":"A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"R13-20230103","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/db07-0982","article-title":"Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"R14-20230103","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6","volume":"127","author":"Scott","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R15-20230103","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5","volume":"127","author":"Ip","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R16-20230103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"R17-20230103","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/IAE.0000000000000843","article-title":"Retinal vein occlusions, from basics to the latest treatment","volume":"36","author":"Ho","year":"2016","journal-title":"Retina"},{"key":"R18-20230103","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","article-title":"Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)","volume":"98","author":"Schmidt-Erfurth","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R19-20230103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"key":"R20-20230103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"key":"R21-20230103","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","article-title":"Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study","volume":"118","author":"Brown","year":"2011","journal-title":"Ophthalmology"},{"key":"R22-20230103","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","article-title":"Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study","volume":"122","author":"Campochiaro","year":"2015","journal-title":"Ophthalmology"},{"key":"R23-20230103","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ophtha.2012.01.042","article-title":"Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study","volume":"119","author":"Boyer","year":"2012","journal-title":"Ophthalmology"},{"key":"R24-20230103","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/bjophthalmol-2012-301504","article-title":"VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study","volume":"97","author":"Holz","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"R25-20230103","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1755-3768.2009.01535.x","article-title":"Retinal vascular events after intravitreal bevacizumab","volume":"88","author":"Mansour","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R26-20230103","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.19082\/5068","article-title":"Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with central retinal vein occlusion: a randomized clinical trial","volume":"9","author":"Motarjemizadeh","year":"2017","journal-title":"Electron Physician"},{"key":"R27-20230103","first-page":"429","article-title":"Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report","volume":"11","author":"Feng","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"R28-20230103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"System Rev"},{"key":"R29-20230103","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R30-20230103","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R31-20230103","doi-asserted-by":"crossref","first-page":"e007768","DOI":"10.1136\/bmjopen-2015-007768","article-title":"Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis","volume":"5","author":"Zhou","year":"2015","journal-title":"BMJ Open"},{"key":"R32-20230103","first-page":"S38","article-title":"Cochrane Handbook for Systematic Reviews of Interventions","volume":"5","author":"Tarsilla","year":"2011","journal-title":"Naunyn-Schmiedebergs Archiv f\u00fcr experimentelle Pathologie und Pharmakologie"},{"key":"R33-20230103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R34-20230103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R35-20230103","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"R36-20230103","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T21:38:28Z","timestamp":1672781908000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022267"}},"subtitle":["A protocol for the systematic review and network meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":36,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022267","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]}}}